American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

IRONWOOD PHARMACEUTICALS INC (IRWD)

$3.51 +0.29% NASDAQ: IRWD · 15-min delayed

BOSTON, Massachusetts
Public · NASDAQ: IRWD
100 employees

Visit website Follow

$610.7MMarket cap

$296.2MRevenue · FY2025

$24.0MNet income

100Employees

IRWDNASDAQ

2010IPO

About IRONWOOD PHARMACEUTICALS INC

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: IRWD
Employees: 100
IPO date: Feb 3, 2010
Headquarters: 100 SUMMER STREET, SUITE 2300
BOSTON, Massachusetts 02110
Phone: 617-621-7722
Industry: Pharmaceuticals
Website: Visit site

Incorporation record

Incorporated in: DE, United States
Registered office: Wilmington, US
Legal entity ID: 549300PC8MR6QHH6P296

Source: GLEIF, the global Legal Entity Identifier registry · checked Jul 26, 2026. A US headquarters does not always mean US incorporation.

Registry IDs

Ticker: IRWD Nasdaq
SEC CIK: 1446847
LEI: 549300PC8MR6QHH6P296
EIN: 043404176
SIC: 2834 PHARMACEUTICAL PREPARATIONS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Ironwood Pharmaceuticals Inc’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/ironwood-pharmaceuticals-inc/"><img src="https://americancompanies.com/badge/ironwood-pharmaceuticals-inc.svg" alt="Ironwood Pharmaceuticals Inc — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow IRONWOOD PHARMACEUTICALS INC and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $296.2M
Net income: $24.0M
Total assets: $396.9M
Market cap: $610.7M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: IRWD

$3.51 +0.29%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$1.27 $5.39

52-week range

Market cap: $610.7M
Shares outstanding: 174.0M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Feb 3, 2010

Ironwood Pharmaceuticals Inc (IRWD) Stock Price

Profitable — net income of $24.0M in FY2025.
Trading 35% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

Peers & competitors

AbbVie Inc.ABBV

No reviews yet. Be the first to review IRONWOOD PHARMACEUTICALS INC.

Write a review

Newsroom

News about IRONWOOD PHARMACEUTICALS INC

Will Linzess Continue to Aid Ironwood's Top-Line Growth in Q3? Zacks Investment Research · 2026-10-07 · positive PGEN vs. IRWD: Which Biotech Stock Offers Better Growth Potential? Zacks Investment Research · 2026-09-30 · positive 3 Stocks Trading Near $5 With Massive Earnings Upside Investing.com · 2026-02-09 · positive Stock Market Today: S&P 500, Nasdaq, WTI Crude Futures Advance After US Strike On Venezuela— GH Research, Vertiv Holdings, Nukkleus In Focus (UPDATED) Benzinga · 2026-01-05 · positive Ironwood Finds a New Floor as LINZESS Net Pricing Turns Into a Growth Lever Investing.com · 2026-01-02 · positive Ironwood Pharmaceuticals Stock Plunges, FDA Wants Another Trial For Gastrointestinal Drug Benzinga · 2025-04-14 · negative

News & sentiment via Polygon.io

FAQ

Ironwood Pharmaceuticals Inc: frequently asked questions

Is Ironwood Pharmaceuticals Inc an American company?

Ironwood Pharmaceuticals Inc is a US-based company headquartered in Boston, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Ironwood Pharmaceuticals Inc headquartered?

Ironwood Pharmaceuticals Inc is headquartered in Boston, Massachusetts, United States.

Is Ironwood Pharmaceuticals Inc publicly traded?

Yes — Ironwood Pharmaceuticals Inc is a publicly traded company. Its stock trades under the ticker symbol IRWD on the NASDAQ.

What does Ironwood Pharmaceuticals Inc do?

Ironwood Pharmaceuticals Inc is an American Pharmaceuticals company in the Health & Beauty sector.

Explore